Scientists identify a new cancer immunotherapy target: Dysfunctional B cells

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood — known as the tertiary lymphoid structure — where they become frustratingly dysfunctional when in close contact with tumors.